{"id":"W4407856069","doi":"10.1016/j.lungcan.2025.108441","title":"Corrigendum to “Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer” [Lung Cancer 195 (2024) 107919]","year":2025,"lang":"en","type":"erratum","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Pfizer (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Anaplastic lymphoma kinase; Cancer research; ALK inhibitor; Tyrosine kinase; Tyrosine-kinase inhibitor; Kinase; Oncology; Internal medicine; Cancer; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003957175,0.0017552,0.002856874,0.003583138,0.0022201,0.003570614,0.002618162,0.007754227,0.08189266],"category_scores_gemma":[0.03781098,0.001177835,0.00316432,0.002484321,0.00114984,0.001350239,0.001382194,0.009352448,0.05601244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006205799,"about_ca_system_score_gemma":0.007370893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06906793,"about_ca_topic_score_gemma":0.128119,"domain_scores_codex":[0.9957322,0.0006486784,0.0006871963,0.0005806966,0.001950872,0.0004003991],"domain_scores_gemma":[0.979993,0.005861344,0.0008045656,0.0008342356,0.01146987,0.001036947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001137199,0.000003625939,0.00002284973,0.00002166096,0.000004201809,0.0000284551,0.000001775307,0.00001699269,0.000006637461,0.00009090751,0.9982868,0.001504721],"study_design_scores_gemma":[0.0001055019,0.00003579001,0.001853934,0.0003395714,0.00007153761,0.0001569769,0.00003189109,0.0003672339,0.0001418148,0.001172127,0.995674,0.00004975295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.00007651535,0.001316246,0.0002715122,0.08966377,0.8954028,0.00004956162,0.003255463,0.0002583211,0.009705767],"genre_scores_gemma":[0.004142354,0.006161931,0.002504593,0.2821421,0.284656,0.000350949,0.007249432,0.0007346181,0.4120581],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.08189266,"threshold_uncertainty_score":0.2739583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01313441767526678,"score_gpt":0.3276319486633341,"score_spread":0.3144975309880673,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}